john.podesta@gmail.comb"Limited Seats Left!\n\nView this email in your browser (http://us5.campaign-archive2.com/?u=c81203f475123a9e28e9c42cd&id=b5ef8718e6&e=4c5c72a395)\n\nhttp://www.plcs.co.in\nDOWNLOAD SUMMIT AGENDA (http://www.plcs.co.in/2015/PLCS_2015_Info_Kit.pdf)\nREGISTER AS A DELEGATE (http://www.plcs.co.in/2015/register.php)\nEXPLORE SPONSORSHIP OPPORTUNITIES (http://www.plcs.co.in/2015/Sponsorship_Deck.pdf)\nINVEST YOUR TIME IN UNDERSTANDING THE COMPLICATIONS OF INVESTMENTS - M&A & FDI\n\nHas FDI in the pharmaceutical sector affected production and availability of cheap drugs? Is there a need to review the current FDI policies? Will the Non-Compete Clause change? How to prepare for expected policy changes? How to prepare yourself and your organization for complicated procedures?\n\nLex Witness brings to you a platform to interact with industry experts. The discussions shall include but not limited to:\n\nM&A AND FDI RIDES OF THE INDIAN PHARMA SECTOR\nDue Diligence\nRegulatory Bodies \xe2\x80\x93 FIPB | DIPP | CCI\nChallenges in executing an M&A Transaction\n\nOther discussions at the summit are:\n\nKEYNOTE SESSION: DEMYSTIFYING COMPLIANCE\nGood Manufacturing Practices | Good Supply Chain Practices\nAnti-Trade/Bribery/Corruption - FCPA, UK Anti-Bribery & PCA\nProduct Promotion - UCPMP & Global Perspective\nVoluntary Disclosure of Non \xe2\x80\x93 Compliance\nPharmacovigilance\nProduct Liability Compliance\n\nFOLLOW UP SESSION - UNLEASHING THE SCIENCES OF TRADEMARKS & COPYRIGHT\nTrademarks Enforcement Issues\nTrade Dress\nMadrid Protocol in India\nCopyright\nINN Names\nTrade Secrets\n\nFOLLOW UP SESSION - AN INSIGHT INTO THE CURRENT PATENT SCENARIO IN INDIA\nPatents as incentives for R&D\nPatent Criteria\nPatent Enforcement\nCompulsory Licensing\nVoluntary Licensing - In Licensing/Out Licensing\nCompliance Protocol of the Indian Patents Act\nChallenges of Introducing a New Product\nGlobal Pressures on Indian IP Policies\nIP Portfolio - Identify, Protect, Valuate, Monetize\nData Exclusivity\n\nFOLLOW UP SESSION - THE REGULATORY SAGAS & THE CHALLENGES WITHIN\nClinical Trials\nDrug Price Control Order 2013\nCompetition Act\nCo Manufacturing & Co Branding Practices\nD&C Act \xe2\x80\x93 Counterfeiting (Misbranding & Adulteration)\nUCPMP & MCI Guidelines\n\nGET INVOLVED\nIn order to participate at PLCS 2015, Mumbai in the form of Speakers, Delegates or Sponsors please get in touch with:\n\nSPEAKING, SPONSORSHIP & DELEGATE QUERIES\nBhupinder Kaur | E: Bhupinder@WitnessLive.in (mailto:Bhupinder@WitnessLive.in) | M: 09654155065\n\nSTRATEGIC ALLIANCES & PARTNERSHIPS\nAkshay Alagh | E: Akshay@WitnessLive.in (mailto:Akshay@WitnessLive.in) | M: 09899332111\n\nLEX WITNESS - INDIA'S 1ST MAGAZINE ON LEGAL & CORPORATE AFFAIRS\nUnit No. 426, 2nd Floor, MG Road, Ghitorni,\nNew Delhi - 110030\nE: plcs@witnesslive.in (mailto:plcs@witnesslive.in)\nT: 91-11-66.56.9793\nwww.witnesslive.in\n\n============================================================\n** (http://www.plcs.co.in)\nCopyright \xc2\xa9 2015 Lex Witness - India's 1st Magazine on Legal & Corporate Affairs, All rights reserved.\n A Lex Witness Industry Connect Initiative\n\nOur mailing address is:\nLex Witness - India's 1st Magazine on Legal & Corporate Affairs\n426, 2nd Floor, Ghitorni, MG Road\nNew Delhi 110030\nIndia\n** unsubscribe from this list (http://witnesslive.us5.list-manage.com/unsubscribe?u=c81203f475123a9e28e9c42cd&id=8eacb30268&e=4c5c72a395&c=b5ef8718e6)\n** update subscription preferences (http://witnesslive.us5.list-manage2.com/profile?u=c81203f475123a9e28e9c42cd&id=8eacb30268&e=4c5c72a395)\n Email Marketing Powered by MailChimp\nhttp://www.mailchimp.com/monkey-rewards/?utm_source=freemium_newsletter&utm_medium=email&utm_campaign=monkey_rewards&aid=c81203f475123a9e28e9c42cd&afl=1"